These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 7312213
1. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy]. Gherzi R, Pastore M, Labate D. Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213 [No Abstract] [Full Text] [Related]
2. Sequential determination of serum human placental lactogen, estriol, and estetrol for assessment of fetal morbidity. Kundu N, Carmody PJ, Didolkar SM, Petersen LP. Obstet Gynecol; 1978 Nov; 52(5):513-20. PubMed ID: 724167 [Abstract] [Full Text] [Related]
4. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy]. Ghionni A, Briani G, Pasini L. Minerva Ginecol; 1979 Nov; 31(1-2):13-8. PubMed ID: 471308 [No Abstract] [Full Text] [Related]
5. [Monitoring of at-risk pregnancies through E3 and HPL]. Bieglmayer C, Spona J. Acta Univ Palacki Olomuc Fac Med; 1981 Nov; 101():38-42. PubMed ID: 6242692 [No Abstract] [Full Text] [Related]
6. Effect of the oxytocin challenge test on levels of maternal serum unconjugated serum estriol and estetrol pre- and post-test in high-risk pregnancies. Sampson MB, Kundu N, Peterson LP. Am J Perinatol; 1986 Jan; 3(1):22-3. PubMed ID: 3942609 [No Abstract] [Full Text] [Related]
7. [At-risk pregnancy (analysis of correlations between parameters)]. Meriggi E, Sanlorenzo F, Colongo E, Parenti MR, Calleri W. Ric Clin Lab; 1978 Jan; 8 Suppl 2():47-57. PubMed ID: 746301 [No Abstract] [Full Text] [Related]
9. Antepartal cardiotocography in the assessment of fetal outcome. Käär K. Acta Obstet Gynecol Scand Suppl; 1980 Jan; 94():1-56. PubMed ID: 6935909 [No Abstract] [Full Text] [Related]
10. Amniotic, urinary and serum hormones in fetal diagnosis. Farquhar JW. Can Med Assoc J; 1971 Jul 24; 105(2):174-6 passim. PubMed ID: 4933694 [No Abstract] [Full Text] [Related]
11. [Placental (HPL, HSAP, CAP) and fetal (estriol in urine and blood) parameters in high risk pregnancies]. Battaglia GB, Morresi G, Coronella L, Messeri G, Valenza T. Quad Sclavo Diagn; 1977 Dec 24; 13(4):434-48. PubMed ID: 351694 [No Abstract] [Full Text] [Related]
12. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy. Garoff L. Obstet Gynecol; 1976 Dec 24; 48(6):659-66. PubMed ID: 63107 [Abstract] [Full Text] [Related]
14. HPL and estriol serum levels of placental perfusion as indexes of placental function in EPH gestosis and placental insufficiency. Gitsch E, Janisch H, Spona J. Gynecol Obstet Invest; 1980 Dec 24; 11(2):102-12. PubMed ID: 7409606 [Abstract] [Full Text] [Related]
15. [Comparative evolution of plasma estriol and hCS in 19 women with a vasculorenal syndrome and presenting with chronic decompensated fetal distress]. Daffos F, Freund M, Sarrot G, Feinstein MC, Grenier J, Chartier M. Sem Hop; 1983 Feb 03; 59(5):306-9. PubMed ID: 6302859 [No Abstract] [Full Text] [Related]
16. Plasma hormone assay in pregnancy. Branconi F, Cariati E, Cappelli G, Paladini S, Scarselli G. Int J Biol Res Pregnancy; 1981 Feb 03; 2(3):146-8. PubMed ID: 6174457 [Abstract] [Full Text] [Related]
18. [Monitoring of EPH-gestosis through the Gestosis Index and hormone determinations]. Weber H. Fortschr Med; 1977 Jul 07; 95(25):1630-34. PubMed ID: 69597 [No Abstract] [Full Text] [Related]
19. [Monitoring of high-risk pregnancies (author's transl)]. Davi D, Vernotico V, Bottoni A, Vallini A, Candi L, Zanella B. Quad Sclavo Diagn; 1978 Dec 07; 14(4):468-85. PubMed ID: 757621 [Abstract] [Full Text] [Related]
20. [Dehydroepiandrosterone sulfate tolerance test in high-risk pregnancy as evaluation of feto-placental insufficiency]. Goisis C, Goisis F, Grossi F. Minerva Ginecol; 1977 May 07; 29(5):369-89. PubMed ID: 142931 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]